Insider Transactions at Aura Biosciences, Inc.

Natalie C. Holles, Chief Executive Officer and President of Aura Biosciences, Inc., reported several transactions on May 19, 2026. She acquired 600,118 shares of Common Stock as part of an Inducement Award RSU, which vests in four equal annual installments starting April 15, 2027. Additionally, she acquired 553,844 shares of Common Stock under a performance RSU award, also subject to time-based vesting and performance conditions, with vesting beginning April 15, 2027. Holles was also granted a Stock Option (Right to Buy) for 2,169,103 shares of Common Stock. This option vests 25% on April 30, 2027, with the remainder vesting over 36 months, subject to continued service. All these transactions were reported as direct ownership with a transaction code "A", indicating acquisition.